TAKEN AVANDIA FOR DIABETES?
If you have suffered a heart attack or stroke and have taken Avandia for Diabetes, then Call the law firm of Benson & Bingham today. 702-382-9797. Rosiglitazone is used along with a diet and exercise program and sometimes with one or more other medications to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Rosiglitazone is in a class of medications called thiazolidinediones. It works by increasing the body’s sensitivity to insulin, a natural substance that helps control blood sugar levels. Rosiglitazone is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may occur if high blood sugar is not treated). Rosiglitazone comes as a tablet to take by mouth. It is usually taken once or twice daily with or without meals. Rosiglitazone should be consumed at about the same time(s) every day. Your doctor may have increased your dose of rosiglitazone after 8-12 weeks, based on your body’s response to the medication. Rosiglitazone claims to help control type 2 diabetes but does not cure it. Usually it takes 2 weeks for your blood sugar to decrease, and 2-3 months or longer for you to feel the full benefit of rosiglitazone. If you need an Avandia Lawyer call the experts at Benson & Bingham today.
U.S. News and World Report Claims there is no real problem with Avandia. “Our observational study does not suggest a significant cardiovascular hazard and may suggest a beneficial effect on ischemic cardiovascular events associated with treatment with rosiglitazone among patients with type 2 diabetes and established coronary artery disease,” said Dr. Richard Bach, an associate professor of medicine at Washington University School of Medicine in St. Louis.
The FDA is on record that the drug is NOT SAFE. It is a matter of time before the drug is pulled off the shelf. FDA previously communicated to the public about the possible association between rosiglitazone and increased cardiovascular risk in a 2007 safety alert. The agency also sought advice from external experts at the July 30th 2007 joint meeting of the FDA Endocrinologic and Metabolic Drugs and Drug Safety and Risk Management Advisory Committees. The RECORD study data represent the only new information from a completed randomized, controlled clinical trial of rosiglitazone received by FDA since the 2007 announcements. The RECORD study was designed to evaluate the cardiovascular safety of rosiglitazone, which is consistent with FDA’s December 2008 Guidance for Industry recommending that manufacturers of new treatments for diabetes carefully design their clinical trials to include an evaluation of cardiovascular safety. The RECORD study will be evaluated in the context of this recent Guidance.
* Rosiglitazone is sold as a single-ingredient product under the brand name Avandia. It is also available in combination with other diabetes medications, metformin under the brand name Avandamet or glimepiride under the brand name Avandaryl.
FDA recommends that patients currently using rosiglitazone: Not stop taking their medication without talking with their healthcare professional. Discuss any questions or concerns they have about rosiglitazone with their healthcare professional. Read the Medication Guide that comes with each rosiglitazone prescription to better understand the risks and benefits of their medication. Report any side effects with rosiglitazone to FDA’s MedWatch program.
Similar to Vioxx, drugs that cause an increase in heart attacks will have serious legal contention if the Plaintiff has other risk factors like obesity, hypertension, high cholesterol, or other issues that may alone cause a heart attack. Those who have diabetes and smoke will also have trouble fighting the makers of Avandia. The biggest risk factor will likely be obesity. Given that fatter humans are likely to have diabetes and therefore develop Type II diabetes, it will be hard to conclusively understand whether the heart issues are from the underlying weight issue or the drug. Studies will continue to give us valuable research to help juries understand the true risks of this drug. To help you fight for your rights, Call the Avandia and other dangerous drug recall attorneys at Benson & Bingham today who are taking new cases today. Don’t delay! 702-382-9797